Pertussis Treatment Market
Pertussis Treatment Market Study by Incubation, Catarrhal, Paroxysmal, and Convalescent Stage Treated by Medications, Vaccinations, and Supportive Treatments from 2024 to 2034
Analysis of Pertussis Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Pertussis Treatment Market Outlook (2024 to 2034)
The global pertussis treatment market size has been projected at a value of US$ 3.8 billion in 2024. The market is forecasted to advance at a CAGR of 3.4% and reach a size of US$ 5.3 billion by the end of 2034.
Pertussis is a respiratory disease, also referred to as whooping cough, which affects the nose and throat. Whooping cough can be treated through medication, vaccination, and/or supportive treatment. Pertussis vaccination administered intravenously is believed to effectively treat whooping cough-causing Borrelia bacteria.
- Worldwide sales of pertussis vaccinations are forecasted to reach US$ 1.37 billion by 2034-end.
- The North American pertussis treatment market size is estimated at US$ 1.48 billion in 2024.
- Western Europe is projected to capture 19.5% of the global pertussis treatment market share by 2034.
Children and infants are most vulnerable to whooping cough, and it can spread quickly from one person to another. This contagious pertussis disease shows symptoms such as low temperature, runny nose, and cough. Immunization or vaccination is one of the best pertussis treatment remedies out there.
- According to the Centers for Disease Control and Prevention (CDC), an estimated 24.1 million cases of pertussis and 160,700 deaths in children younger than age 5 years are recorded annually, worldwide.
- As per the article 'Highly contagious Whooping Cough spreads globally; Know all about its causes, symptoms and treatment', published by Financial Express on 12th April 2024, cases of whooping cough are increasing rapidly across the world, especially in the United Kingdom, China, the Philippines, Czech Republic, the Netherlands, and the United States.
| Report Attribute | Detail |
|---|---|
| Pertussis Treatment Market Size (2024E) | US$ 3.8 Billion |
| Forecasted Market Value (2034F) | US$ 5.3 Billion |
| Global Market Growth Rate (2024 to 2034) | 3.4% CAGR |
| South Korea Market Size (2024E) | US$ 131 Million |
| Canada Market Growth Rate (2024 to 2034) | 5.1% CAGR |
| Market Share of Parenteral Pertussis Drugs (2034) | 30.3% |
| Key Companies Profiled | Johnson & Johnson Services Inc.; GlaxoSmithKline, Plc.; Merck & Co. Inc.; Sanofi; Pfizer Inc.; Novartis AG; Panacea Biotech; China National Biotec Group; Changchun Changsheng Life Sciences; Daiichi Sankyo Company Ltd.; Mylan NV; Boehringer Ingelheim International GmbH; Bristol Myers Squibb Company; Mitsubishi Tanabe Pharma; Astellas Pharma; Shenzhen KangTai Biological Products. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What’s Positively Influencing Sales of Pertussis Drugs Across the World?
“Rising Prevalence of New and Old Contagious Diseases Driving Investments in Innovative Drug Production”
The prevalence of contagious diseases has been increasing across the globe. Urbanization, living in more densely populated areas, surge in traveling activities, and increasing pet ownership are some of the key factors giving rise to concerns about new infectious diseases. There is also a high chance that infectious diseases can get transferred from animals to humans.
The recent COVID pandemic is the best example of the risks of contagious disease. Governments in several countries are investing in R&D activities to introduce effective vaccinations and medications. The rising prevalence of infectious diseases, including whooping cough, is set to drive demand for target treatments.
“Advancements in Polymerase Chain Reaction (PCR) and Serological Assays”
A notable pertussis treatment market trend is rapid advancements in diagnostic technologies, including polymerase chain reaction (PCR) and serological assays.
- According to the European Centre for Disease Prevention and Control, for patients coughing for 2 to 3 weeks or longer, serologic diagnosis is an effective method for pertussis detection.
- The Centers for Disease Control and Prevention (CDC) estimates that the polymerase chain reaction (PCR) is a vital and effective molecular technique to detect Bordetella pertussis bacterium.
Polymerase chain reaction can effectively detect small amounts of bacterial DNA from Bordetella pertussis bacterium. High sensitivity aids in accurate and earlier diagnosis compared to traditional methods. Serological assays offer vital information on past exposure or immunity status, helping in epidemiological studies and vaccine efficacy assessments.
What’s Denting the Profits of Pertussis Treatment Solution Providers?
“High Cost of Pertussis Medicine Production and Storage”
Developing vaccines needs extremely high capital investments. Substantial investments in research and development activities have led to the production of effective and reliable pertussis vaccinations, drugs, medications, and other therapeutic solutions. Also, the storage and shipping costs of vaccines are higher than other pharma medications since they need special monitoring and transportation solutions.
Lack of appropriate storage and transport facilities is a key factor hampering whooping cough vaccine quality and shelf life. Thus, from in vitro research to marketing, pertussis medicine requires significant investments. Therefore, this high cost of vaccine production is limiting global pertussis treatment market growth to some extent.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Can New Companies Bolster Their Market Presence?
“Focus on Development of Innovative Treatment Approaches”
New companies should focus on investing in R&D for the development of novel therapies or innovative drug production. Advancements in pertussis therapeutics will help them stand apart from the crowd. New drug or vaccine formulations, delivery methods, and combination therapies aimed at enhancing efficacy and patient compliance will be key in this business space.
Country-wise Analysis
Why is Demand for Pertussis Therapeutics Rising in the United States?
“Increasing Prevalence of Pertussis and Presence of Advanced Healthcare Facilities”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.29 Billion |
| Growth Rate (2024 to 2034) | 3.9% CAGR |
| Projected Value (2034F) | US$ 1.89 Billion |
- According to a Centers for Disease Control and Prevention (CDC) report, around 5,611 people in the United States were detected with pertussis in 2023.
This rising prevalence of pertussis in the country is driving high demand for effective therapeutic solutions. Presence of cutting-edge healthcare facilities and continuous advancements in diagnostic technologies are set to drive pertussis treatment demand growth in the country over the coming years.
What is the Demand Outlook for Pertussis Medications in Japan?
“Large Older Demographic More Susceptible to Pertussis Disease”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 163.3 Million |
| Growth Rate (2024 to 2034) | 1.1% CAGR |
| Projected Value (2034F) | US$ 181.9 Million |
Large aging population in Japan has led to increased susceptibility to infectious diseases, including pertussis. This risk of pertussis among older people will drive the need for effective treatment solutions in the country. Health campaigns and education initiatives conducted by the government are also contributing to market growth in Japan. Availability of advanced diagnostic techniques and medications will benefit pertussis therapeutic providers in the country.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
Which Mode of Purchase is Most Relied on for Pertussis Medications?
“Rx Mode of Purchase Most Prevalent Worldwide”
| Attribute | Rx Mode of Purchase |
|---|---|
| Segment Value (2024E) | US$ 2.9 Billion |
| Growth Rate (2024 to 2034) | 3.4% CAGR |
| Projected Value (2034F) | US$ 4.04 Billion |
Pertussis severity and complications can vary based on when and how it is detected. A majority of patients prefer treatment from hospitals or specialized clinics. Accordingly, doctors need to prescribe effective and safe medications to patients. This factor makes Rx or prescribed pertussis medications the most prevalent in the market, with the segment accounting for over three-fourths of sales.
Which is the Prime Distribution Channel for Pertussis Drugs and Medications?
“Hospital Pharmacies Lead Sales of Pertussis Medications”
| Attribute | Hospital Pharmacies |
|---|---|
| Segment Value (2024E) | US$ 1.52 Billion |
| Growth Rate (2024 to 2034) | 3.1% CAGR |
| Projected Value (2034F) | US$ 2.07 Billion |
As already mentioned, most patients primarily prefer hospitals for pertussis treatment and other infectious diseases. Direct patient access allows hospital pharmacies to ensure timely and appropriate dispensation of medications to target patients. Hospital pharmacies are equipped with skilled pharmacists and stocked with advanced medications. This leads to the high sales of pertussis medications through hospital pharmacies.
Competitive Landscape
Key players in the pertussis treatment market are adopting several organic and inorganic strategies such as mergers & acquisitions, collaborations, partnerships, new product offerings, and regional expansion to stay ahead of the competition. They are partnering with other companies to increase their market reach. Collaborating with research institutions is also aiding in increasing their product offerings.
- 25 March 2024: As per a press release by EurekAlert, researchers from the American Society for Biochemistry and Molecular Biology uncovered a key biomolecule involved in pertussis infection. The discovery is expected to aid in creating a new drug or vaccine for whooping cough.
Fact.MR provides detailed information about the price points of key providers of pertussis treatment solutions positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
Key Segments of Pertussis Treatment Market Research
-
By Type :
- Medications
- Vaccinations
- Supportive Treatments
- Others
-
By Diagnosis :
- Blood Tests
- Chest X-Rays
- Nose or Throat Culture & Tests
-
By Mode of Purchase :
- Rx
- OTC
-
By Route of Administration :
- Oral
- Parenteral
- Others
-
By Disease Stage :
- Incubation Stage
- Catarrhal Stage
- Paroxysmal Stage
- Convalescent Stage
-
By Distribution Channel :
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Type
- 6.2. Diagnosis
- 6.3. Mode of Purchase
- 6.4. Route of Administration
- 6.5. Distribution Channel
- 6.6. Disease Stage
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Type
- 7.1. Medications
- 7.2. Vaccinations
- 7.3. Supportive Treatments
- 7.4. Others
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Diagnosis
- 8.1. Blood Tests
- 8.2. Chest X-Rays
- 8.3. Nose or Throat Culture & Tests
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Mode of Purchase
- 9.1. Rx
- 9.2. OTC
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Route of Administration
- 10.1. Oral
- 10.2. Parenteral
- 10.3. Others
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 11.1. Hospital Pharmacies
- 11.2. Online Pharmacies
- 11.3. Retail Pharmacies
- 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Disease Stage
- 12.1. Incubation Stage
- 12.2. Catarrhal Stage
- 12.3. Paroxysmal Stage
- 12.4. Convalescent Stage
- 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 13.1. North America
- 13.2. Latin America
- 13.3. Western Europe
- 13.4. Eastern Europe
- 13.5. East Asia
- 13.6. South Asia & Pacific
- 13.7. Middle East & Africa
- 14. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 20. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 21. Sales Forecast 2024 to 2034 by Type, Diagnosis, Mode of Purchase, Route of Administration, Distribution Channel, Disease Stage, and Region for 30 Countries
- 22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 23. Company Profile
- 23.1. Johnson & Johnson Services Inc.
- 23.2. GlaxoSmithKline, Plc.
- 23.3. Merck & Co. Inc.
- 23.4. Sanofi
- 23.5. Pfizer Inc.
- 23.6. Novartis AG
- 23.7. Panacea Biotech
- 23.8. China National Biotec Group
- 23.9. Changchun Changsheng Life Sciences
- 23.10. Daiichi Sankyo Company Ltd.
- 23.11. Mylan NV
- 23.12. Boehringer Ingelheim International GmbH
- 23.13. Bristol Myers Squibb Company
- 23.14. Mitsubishi Tanabe Pharma
- 23.15. Astellas Pharma
- 23.16. Shenzhen KangTai Biological Diagnosiss
- 24. Assumptions and Acronyms Used
- 25. Research Disease Stageology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 16: Global Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 17: Global Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 18: Global Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 19: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 20: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 21: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 31: North America Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 32: North America Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 33: North America Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 34: North America Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 35: North America Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 36: North America Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 37: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 38: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 39: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 40: North America Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 41: North America Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 42: North America Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 46: Latin America Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 47: Latin America Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 49: Latin America Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 50: Latin America Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 51: Latin America Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 52: Latin America Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 53: Latin America Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 54: Latin America Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 55: Latin America Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 56: Latin America Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 57: Latin America Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 58: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 59: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 60: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 61: Latin America Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 62: Latin America Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 63: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 64: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: Western Europe Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 68: Western Europe Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 69: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 70: Western Europe Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 71: Western Europe Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 72: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 73: Western Europe Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 74: Western Europe Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 75: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 76: Western Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 77: Western Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 78: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 79: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 80: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 81: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 82: Western Europe Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 83: Western Europe Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 84: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 85: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 86: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 87: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 88: Eastern Europe Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 89: Eastern Europe Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 90: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 91: Eastern Europe Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 92: Eastern Europe Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 93: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 94: Eastern Europe Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 95: Eastern Europe Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 96: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 97: Eastern Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 98: Eastern Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 99: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 100: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 101: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 102: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 103: Eastern Europe Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 104: Eastern Europe Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 105: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 106: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 107: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 108: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 109: East Asia Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 110: East Asia Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 111: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 112: East Asia Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 113: East Asia Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 114: East Asia Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 115: East Asia Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 116: East Asia Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 117: East Asia Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 118: East Asia Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 119: East Asia Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 120: East Asia Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 121: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 122: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 123: East Asia Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 124: East Asia Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 125: East Asia Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 126: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 127: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 128: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 129: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 130: South Asia & Pacific Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 131: South Asia & Pacific Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 132: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 133: South Asia & Pacific Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 134: South Asia & Pacific Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 135: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 136: South Asia & Pacific Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 137: South Asia & Pacific Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 138: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 139: South Asia & Pacific Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 140: South Asia & Pacific Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 141: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 142: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 143: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 144: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 145: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 146: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 147: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
Table 148: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 149: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 150: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 151: MEA Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 152: MEA Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 153: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 154: MEA Market Value (US$ Mn) Analysis, by Diagnosis, 2019 to 2023
Table 155: MEA Market Value (US$ Mn) Analysis, by Diagnosis, 2024 to 2034
Table 156: MEA Market Value (US$ Mn) Opportunity Analysis, by Diagnosis, 2024 to 2034
Table 157: MEA Market Value (US$ Mn) Analysis, by Mode of Purchase, 2019 to 2023
Table 158: MEA Market Value (US$ Mn) Analysis, by Mode of Purchase, 2024 to 2034
Table 159: MEA Market Value (US$ Mn) Opportunity Analysis, by Mode of Purchase, 2024 to 2034
Table 160: MEA Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 161: MEA Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 162: MEA Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 163: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 154: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 165: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 166: MEA Market Value (US$ Mn) Analysis, by Disease Stage, 2019 to 2023
Table 167: MEA Market Value (US$ Mn) Analysis, by Disease Stage, 2024 to 2034
Table 168: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease Stage, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Type, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Type, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 20: Global Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 21: Global Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 22: Global Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 23: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 24: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 25: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 26: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 27: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 28: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 29: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 30: North America Market Share Analysis by Country, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Type, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Type, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 39: North America Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 40: North America Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 41: North America Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 42: North America Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 43: North America Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 44: North America Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 45: North America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 46: North America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 47: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 48: North America Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 49: North America Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 50: North America Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 51: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 52: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 53: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 54: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 55: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 59: Latin America Market Share and BPS Analysis by Type, 2024 & 2034
Figure 59: Latin America Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 60: Latin America Market Attractiveness Analysis by Type, 2024 to 2034
Figure 61: Latin America Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 62: Latin America Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 63: Latin America Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 64: Latin America Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 65: Latin America Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 66: Latin America Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 67: Latin America Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 68: Latin America Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 69: Latin America Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 70: Latin America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 71: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 72: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 73: Latin America Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 74: Latin America Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 75: Latin America Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 77: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 78: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 79: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 80: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 81: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 82: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 83: Western Europe Market Share and BPS Analysis by Type, 2024 & 2034
Figure 84: Western Europe Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 85: Western Europe Market Attractiveness Analysis by Type, 2024 to 2034
Figure 86: Western Europe Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 87: Western Europe Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 88: Western Europe Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 89: Western Europe Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 90: Western Europe Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 91: Western Europe Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 92: Western Europe Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 93: Western Europe Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 94: Western Europe Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 95: Western Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 96: Western Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 97: Western Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 98: Western Europe Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 99: Western Europe Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 100: Western Europe Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 102: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 103: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 104: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 105: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 105: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 107: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 108: Eastern Europe Market Share and BPS Analysis by Type, 2024 & 2034
Figure 109: Eastern Europe Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 110: Eastern Europe Market Attractiveness Analysis by Type, 2024 to 2034
Figure 111: Eastern Europe Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 112: Eastern Europe Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 113: Eastern Europe Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 114: Eastern Europe Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 115: Eastern Europe Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 116: Eastern Europe Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 117: Eastern Europe Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 118: Eastern Europe Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 120: Eastern Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 121: Eastern Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 122: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 123: Eastern Europe Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 124: Eastern Europe Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 125: Eastern Europe Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 126: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 127: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 128: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 129: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 130: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 131: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 132: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 133: East Asia Market Share and BPS Analysis by Type, 2024 & 2034
Figure 134: East Asia Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 135: East Asia Market Attractiveness Analysis by Type, 2024 to 2034
Figure 136: East Asia Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 137: East Asia Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 138: East Asia Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 139: East Asia Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 140: East Asia Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 141: East Asia Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 142: East Asia Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 143: East Asia Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 144: East Asia Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 145: East Asia Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 146: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 147: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 148: East Asia Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 149: East Asia Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 150: East Asia Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 151: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 152: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 153: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 154: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 155: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 156: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 157: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 158: South Asia & Pacific Market Share and BPS Analysis by Type, 2024 & 2034
Figure 159: South Asia & Pacific Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 160: South Asia & Pacific Market Attractiveness Analysis by Type, 2024 to 2034
Figure 161: South Asia & Pacific Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 162: South Asia & Pacific Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 163: South Asia & Pacific Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 164: South Asia & Pacific Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 165: South Asia & Pacific Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 166: South Asia & Pacific Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 167: South Asia & Pacific Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 168: South Asia & Pacific Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 169: South Asia & Pacific Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 170: South Asia & Pacific Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 171: South Asia & Pacific Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 172: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 173: South Asia & Pacific Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 174: South Asia & Pacific Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 175: South Asia & Pacific Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Figure 176: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 177: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 178: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 179: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 180: MEA Market Share Analysis by Country, 2024 & 2034
Figure 181: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 182: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 183: MEA Market Share and BPS Analysis by Type, 2024 & 2034
Figure 184: MEA Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 185: MEA Market Attractiveness Analysis by Type, 2024 to 2034
Figure 186: MEA Market Share and BPS Analysis by Diagnosis, 2024 & 2034
Figure 187: MEA Market Y-o-Y Growth Projections by Diagnosis, 2024 to 2034
Figure 188: MEA Market Attractiveness Analysis by Diagnosis, 2024 to 2034
Figure 189: MEA Market Share and BPS Analysis by Mode of Purchase, 2024 & 2034
Figure 190: MEA Market Y-o-Y Growth Projections by Mode of Purchase, 2024 to 2034
Figure 191: MEA Market Attractiveness Analysis by Mode of Purchase, 2024 to 2034
Figure 192: MEA Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 193: MEA Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 194: MEA Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 195: MEA Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 196: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 197: MEA Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 198: MEA Market Share and BPS Analysis by Disease Stage, 2024 & 2034
Figure 199: MEA Market Y-o-Y Growth Projections by Disease Stage, 2024 to 2034
Figure 200: MEA Market Attractiveness Analysis by Disease Stage, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current valuation of the pertussis treatment market?
The global pertussis treatment market is estimated at US$ 3.8 billion in 2024.
What is the projected size of the pertussis treatment market for 2034?
The market for pertussis treatment is projected to reach US$ 5.3 billion by 2034.
What are the projections for pertussis treatment solutions?
The global market is forecasted to register expansion at a CAGR of 3.4% through 2034.
How fast are the sales of pertussis therapeutic solutions expected to increase in India?
Demand for pertussis treatment in India is projected to rise at a CAGR of 5.3% from 2024 to 2034.
How much are the sales of pertussis vaccinations estimated in 2024?
Revenue from pertussis vaccinations is approximated at US$ 984.7 million in 2024.
Who are the leading producers of pertussis therapeutic solutions?
Some of the leading companies are Johnson & Johnson Services Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Sanofi, Pfizer Inc., Novartis AG, and Panacea Biotech.
How big is the market in North America?
The North American market is estimated at US$ 1.48 billion in 2024.
What are the current treatment options for pertussis?
Medications, vaccinations, and supportive treatments are the most popular options to treat pertussis.
What is the gold standard for the treatment of pertussis?
Oral drugs are the gold standard for the treatment of pertussis.
What is the first line of treatment for pertussis?
Erythromycin is known as the first-line treatment for pertussis.
Pertussis Treatment Market